FDA Recall Checker | Semaglutide & Tirzepatide

Check Your Medication

Verify if your Semaglutide or Tirzepatide vial is affected by the FDA recall

✓ Important Update for Fifty 410 Customers

We are continuing to gather detailed information regarding the recent recall, which was voluntarily initiated by ProRx. According to the FDA, the affected medications include certain Semaglutide products (which we do not dispense) and the 27 mg vial of Tirzepatide, which we also do not dispense. All Fifty 410 programs exclusively utilize the 9 mg, 45 mg, and 72 mg vials of Tirzepatide.

At this time, based on all information currently available, there is no indication that any Fifty 410 customers are affected by this recall.

We want to assure our customers that their safety and well-being remain our highest priority.

We are actively communicating with the pharmacy and regulatory partners to confirm all details. An official update will be shared tomorrow afternoon once we have completed our review. We will continue to keep our customers fully informed as more information becomes available.

ℹ️ FDA Class II Medical Recall Information
This recall affects certain lots due to lack of assurance of sterility. Manufactured by ProRx, 619 Jeffers Cir, Exton, PA 19341. Consult your healthcare provider before stopping any medication.

How to Check Your Lot Number

1
Locate your Semaglutide or Tirzepatide vial
2
Find "LOT", "Lot #", or "Batch" on the label
3
ProRx lot numbers typically start with "PRORX"
4
Enter your lot number below to check

    Affected Lot Numbers

    View Full FDA Recall Details ↗